Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
OtherImaging (JNMT)

Mib1 index stratified assessment of Dual Tracer PET-CT with 68Ga-DOTATATE and 18F-FDG and multimodality anatomical imaging in Metastatic NET of Unknown Primary (CUP-NET) scheduled for PRRT

Nikita Sampathirao and Sandip Basu
Journal of Nuclear Medicine Technology February 2017, jnmt.116.185777; DOI: https://doi.org/10.2967/jnmt.116.185777
Nikita Sampathirao
1 Radiation Medicine Centre, Bhabha Atomic Research Centre, India;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandip Basu
2 RADIATION MEDICINE CENTRE (BARC), Tata Memorial Hospital Annexe, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Abstract

Aim: Comparative assessment of dual tracer PET/CT (68Ga-DOTATATE and 18F-FDG) and multimodality anatomical imaging in studying CUP-NETs scheduled for PRRT for: (i) divergence of tracer uptake on dual tracer PET/CT, (ii) detection of primary and (iii) overall lesion detection vis-a-vis tumor proliferation index (Mib1/Ki-67). Materials and Methods: Fifty-one patients of CUP-NETs (M:F=25:26, age:22-74 years), histopathologically proven and thoroughly investigated with conventional imaging modalities (USG, CT/ceCT, MRI and EUS, wherever applicable), were retrospective analyzed. They were primarily referred for deciding on feasibility of PRRT (except 2 patients) and all had undergone 68Ga-DOTATATE and 18F-FDG PET/CT as part of pre-treatment work up. The sites of metastases included liver, lung/mediastinum, skeleton, abdominal nodes and other soft tissue sites. Patients were divided into 5 groups based on Mib1/Ki-67 index of 5 point scale: group I (1-5%) (n = 35), group II (6-10%) (n = 8), group III (11-15%) (n = 4), group IV (16-20%) (n = 2), group V (>20%) (n = 2). Semiquantitative analysis of tracer uptake was undertaken by SUVmax of metastatic lesions and the primary (when detected). The SUVmax values were studied over increasing Mib1/Ki67 index. The detection sensitivity of 68Ga-DOTATATE for primary and metastatic lesions was assessed and compared with other imaging modalities including 18F-FDG-PET/CT. Results: Unknown primary was detected on 68Ga-DOTATATE in 31/51 patients resulting in sensitivity of 60.78% while overall lesion detection sensitivity was 96.87%. The overall lesion detection sensitivities (individual group-wise from Group I to Group V) were 97.75%, 87.5%, 100%, 100% and 66.67% respectively. As Mib1/Ki67 index increased, 68Ga-DOTATATE uptake decreased in metastatic and primary lesions (mean SUVmax 43.5 and 22.68 g/dl in group I to 22.54 and 16.83 g/dl in group V respectively), while 18F-FDG uptake showed a gradual rise (mean SUVmax 3.66 and 2.86 g/dl in group I to 7.53 and 9.58 g/dl in group V respectively). There was corresponding decrease in 68Ga-DOTATATE/18F-FDG uptake ratio with increasing Mib1/Ki-67 index (from 11.89 in group I to 2.99 in group V). Conclusion: In CUP-NETs, pattern of uptake on dual tracer PET (68Ga-DOTATATE/18F-FDG) correlates well with tumor proliferation index with a few outliers; combined dual tracer PET/CT with Mib1/Ki-67 index would aid in better whole-body assessment of tumour biology in CUP-NETs.

  • Oncology: Endocrine
  • PET/CT
  • 68Ga-DOTATATE PET-CT
  • FDG-PET/CT
  • Metastatic NET of Unknown Primary (CUP-NET)
  • NEUROENDOCRINE TUMOUR
Next
Back to top

In this issue

Journal of Nuclear Medicine Technology: 53 (1)
Journal of Nuclear Medicine Technology
Vol. 53, Issue 1
March 1, 2025
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mib1 index stratified assessment of Dual Tracer PET-CT with 68Ga-DOTATATE and 18F-FDG and multimodality anatomical imaging in Metastatic NET of Unknown Primary (CUP-NET) scheduled for PRRT
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Mib1 index stratified assessment of Dual Tracer PET-CT with 68Ga-DOTATATE and 18F-FDG and multimodality anatomical imaging in Metastatic NET of Unknown Primary (CUP-NET) scheduled for PRRT
Nikita Sampathirao, Sandip Basu
Journal of Nuclear Medicine Technology Feb 2017, jnmt.116.185777; DOI: 10.2967/jnmt.116.185777

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Mib1 index stratified assessment of Dual Tracer PET-CT with 68Ga-DOTATATE and 18F-FDG and multimodality anatomical imaging in Metastatic NET of Unknown Primary (CUP-NET) scheduled for PRRT
Nikita Sampathirao, Sandip Basu
Journal of Nuclear Medicine Technology Feb 2017, jnmt.116.185777; DOI: 10.2967/jnmt.116.185777
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Discordance Between Histopathologic Grading and Dual-Tracer PET/CT Findings in Metastatic NETs and Outcome of 177Lu-DOTATATE PRRT: Does In Vivo Molecular PET Perform Better from the Viewpoint of Prediction of Tumor Biology?
  • Google Scholar

Similar Articles

Keywords

  • Oncology: Endocrine
  • PET/CT
  • 68Ga-DOTATATE PET-CT
  • FDG-PET/CT
  • Metastatic NET of Unknown Primary (CUP-NET)
  • Neuroendocrine Tumour
SNMMI

© 2025 SNMMI

Powered by HighWire